Tag: repotrectinib

(CercleFinance.com) – Bristol Myers Squibb today announced updated results from a study demonstrating that repotrectinib – a tyrosine kinase (TKI) inhibitor – continues to show high and durable response rates…

Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…